SCHEMBL1709649

SCHEMBL1709649

CCNCc1n[nH]c([C@@H](CCc2ccccc2)NS(=O)(=O)CCCN(CC)CC)n1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.68
CCR4 P51679 2/20 0.36
ALDH1A1 P00352 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KCNH2 Q12809 2/20 0.34
CHRM2 P08172 1/20 0.34
HTR1A P08908 1/20 0.34
ADRA2A P08913 1/20 0.34
CHRM1 P11229 1/20 0.34
DRD1 P21728 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
ADRA1A P35348 1/20 0.34
OPRM1 P35372 1/20 0.34
DRD3 P35462 1/20 0.34
SLC6A3 Q01959 1/20 0.34
GAA P10253 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10121964 0.92 GHSR (0.69) GHSRCCR4ALDH1A1CYP1A2CYP2C9
SCHEMBL1709684 0.90 GHSR (0.62) GHSRCCR4ALDH1A1CYP1A2CYP2C9
SCHEMBL10121926 0.89 GHSR (0.67) GHSRCCR4ALDH1A1CYP1A2CYP2C9
SCHEMBL1709708 0.89 GHSR (0.67) GHSRCCR4ALDH1A1CYP1A2CYP2C9
SCHEMBL10122103 0.89 GHSR (0.65) GHSRCCR4ALDH1A1CYP1A2KCNH2
SCHEMBL10121676 0.88 GHSR (0.64) GHSRCCR4ALDH1A1OPRM1GAA
SCHEMBL10121682 0.88 GHSR (0.69) GHSRCCR4CYP1A2KCNH2CHRM2
SCHEMBL10121950 0.88 GHSR (0.64) GHSRCCR4ALDH1A1GAASCN1A
SCHEMBL10121683 0.87 GHSR (0.63) GHSRCCR4ALDH1A1CYP1A2CYP2C9
SCHEMBL1709677 0.87 GHSR (0.63) GHSRCCR4GAASCN1ASCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885CCR4 3489/4885ALDH1A1 3182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.